INSIGHTS ON DRUG DEVELOPMENT

• Early Automation Integration Reshapes How Drugs Move

  Introducing automation during R&D rather than in Phase 3 changes how processes scale. Unified data and standards-based control logic carry across bench, pilot, and commercial stages with less rework.

• White Paper: Characterization Of Spray Dried Biologics

  Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.

• Amorphous Stability: Mesoporous Silica For Poor Glass Formers

  Discover how mesoporous silica outperforms polymeric solid dispersions in stabilizing poor glass formers, as well as how it offers a novel approach to enhance amorphous drug stability and bioavailability.

• Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs)

  ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.

• Outlining The Trends And Challenges In The Inhaled Drug Delivery Market

  10/21/2024

  Explore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.

• Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

  3/31/2025

  Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.

• Innovating The mAb Characterization Process

  11/14/2024

  Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.

• The Power Of Derivatization: Simple Solutions To Complex Analytical Problems

  9/23/2026

  Derivatization can improve detection, separation, and quantification, providing a practical solution for challenging analyses while supporting reliable quality control and regulatory compliance.

• A Timeline Of U.S. Actions To Reduce Animal Models In Research

  6/25/2026

  Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.